Page 3 - Sciences Ltd News Today

Relief Therapeutics (OTCMKTS:RLFTF – Get Free Report) and Roivant Sciences (NASDAQ:ROIV – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations and dividends. Analyst Ratings This is a breakdown of recent […]

Max Healthcare Institute Ltd tanked 7.68 per cent to Rs 734. Shares of KIMS fell 3.23 per cent to Rs 2,182. Narayana Hrudayalaya shares declined 1.66 per cent to Rs 1,311.70.

Deerfield Management Company L.P. Series C raised its position in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 18.4% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,604,487 shares of the company’s stock after acquiring an additional 249,513 shares during […]

Wolfe Research started coverage on shares of Roivant Sciences (NASDAQ:ROIV – Free Report) in a research note published on Thursday, Marketbeat reports. The brokerage issued an outperform rating and a $17.00 price target on the stock. A number of other equities analysts have also recently commented on ROIV. Deutsche Bank Aktiengesellschaft started coverage on shares […]

Silverarc Capital Management LLC purchased a new position in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 100,000 shares of the company’s stock, valued at approximately $1,168,000. A number of other institutional investors have also recently […]

Roivant Sciences (NASDAQ:ROIV – Get Free Report) had its target price reduced by stock analysts at HC Wainwright from $18.00 to $17.00 in a research note issued on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s target price would suggest a potential upside of 54.26% from the company’s […]

Investors are hopeful that small- and mid-cap stocks will experience a broader rally this year after getting hammered for most part of the previous year as all eyes remain focused on the Magnificent Seven...

Oncolytics Biotech (NASDAQ:ONCY – Get Free Report) and Roivant Sciences (NASDAQ:ROIV – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends. Earnings & Valuation This table compares Oncolytics Biotech […]

Index of Sciences Ltd represents a unique blend of scientific rigor and accessibility, striving to empower people with health knowledge and scientific understanding.